Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children

Haematologica

Volumn 98, Issue 5, 2013, Pages 802-807

  Goldenberg, Neil A ^a,b   Bernard, Timothy J ^c,d   Hillhouse, Jasper ^c   Armstrong Wells, Jennifer ^c,d   Galinkin, Jeffrey ^c   Knapp Clevenger, Rhonda ^c   Jacobson, Linda ^c   Marcovina, Santica M ^e   Manco Johnson, Marilyn J ^c,d  

^a JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d Children's Hospital Colorado   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN A;

ADOLESCENT; ADULT; ARTICLE; ATHEROGENESIS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUGLOBULIN LYSIS TEST; FEMALE; FIBRINOLYSIS; HUMAN; INFANT; MALE; NORTH AMERICA; OUTCOME ASSESSMENT; PREVALENCE; PROSPECTIVE STUDY; RECURRENT DISEASE; BLOOD; CASE CONTROL STUDY; INCIDENCE; PRESCHOOL CHILD; RISK; STROKE; UNITED STATES; YOUNG ADULT;

ADOLESCENT; APOPROTEIN(A); CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLORADO; FEMALE; FIBRINOLYSIS; HUMANS; INCIDENCE; INFANT; LIPOPROTEIN(A); MALE; PREVALENCE; RISK; STROKE; YOUNG ADULT;

EID: 84877030759     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.073833     Document Type: Article

References (27)

1. McLean JW, Tomlinson JE, Kuang W-J, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987; 330:132-7.
2. Keesler GA, Gabel BR, Devlin CM, Koschinsky ML, Tabas I. The binding activity of the macrophage lipoprotein(a)/ apolipoprotein(a) receptor is induced by cholesterol via a post-translational mechanism and recognizes distinct kringle domains on apolipoprotein(a). J Biol Chem. 1996; 271:32096-104.
3. Edelstein C, Pfaffinger D, Hinman J, Miller E, Lipkind G, Tsimikas S, et al. Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential proinflammatory properties to human apolipoprotein(a). J Biol Chem. 2003;278 (52):52841-7.
4. Koschinsky ML, Marcovina SM. Structurefunction relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity. Curr Opin Lipidol. 2004; 15(2):167-74.
5. Erqou S, Thompson A, Di Angelantonio E, Saleheen D, Kaptoge S, Marcovina S, Danesh J. Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants. J Am Coll Cardiol. 2010;55(19):2160-7.
6. Fullerton HJ, Wu YW, Sidney S, Johnston SC. Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics. 2007;119(3):495-501.
7. Schoenberg BS, Mellinger JF, Schoenberg DG. Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology. 1978;28(8): 763-8.
8. Nelson K, Lynch JK. Stroke in newborn infants. Lancet Neurol. 2004;3(3):150-8.
9. Goldenberg NA, Bernard TJ, Fullerton HJ, Gordon A, deVeber G; International Pediatric Stroke Study Group. Antithrombotic treatments, outcomes, and prognostic factors in acute childhood-onset arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet Neurol. 2009;8(12):1120-7.
10. Chabrier S, Husson B, Lasjaunias P, Landrieu P, Tardieu M. Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients. J Child Neurol. 2000;15(5):290-4.
11. Steinlin M, Pfister I, Pavlovic J, Everts R, Boltshauser E, Capone MA, et al.; Swiss Societies of Paediatric Neurology and Neonatology. The first three years of the Swiss Neuropaediatric Stroke Registry (SNPSR): a population-based study of incidence, symptoms and risk factors. Neuropediatrics. 2005;36(2):90-7.
12. deVeber GA, MacGregor D, Curtis R, Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol. 2000;15(5):316-24.
13. Sträter R, Becker S, von Eckardstein A, Heinecke A, Gutsche S, Junker R, et al. Prospective assessment of risk factors of recurrent stroke during childhood: a 5-year follow-up study. Lancet. 2002;360(9345): 1540-5.
14. Bernard TJ, Goldenberg NA. Pediatric arterial ischemic stroke. Hematol Oncol Clinics North Am. 2010;24(1):167-80.
15. Emerging Risk Factors Collaboration, Erqou S, Kaptoge S, Perry PL, Di Angelantonio E, Thompson A, White IR, et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009;302(4):412-23.
16. Nowak-Göttl U, Sträter R, Heinecke A, Junker R, Koch HG, Schuierer G, von Eckardstein A. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood. 1999; 94(11):3678-82.
17. Lynch JK, Han CJ, Nee LE, Nelson KB. Prothrombotic factors in children with stroke or porencephaly. Pediatrics. 2005; 116(2):447-53.
18. Renaud C, Bonneau C, Presles E, Laporte S, Depeyre A, Varlet MN, Chabrier S;AVCnn Group. Lipoprotein (a), birth weight and neonatal stroke. Neonatology. 2010;98(3): 225-8.
19. Bernard TJ, Manco-Johnson MJ, Lo W, MacKay MT, Ganesan V, DeVeber G, et al. Towards a consensus-based classification of childhood arterial ischemic stroke. Stroke. 2012;43(2):371-7.
20. Marcovina SM, Albers JJ, Gabel B, Koschinsky ML, Gaur VP. Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem. 1995;41(2):246-55.
21. Marcovina SM, Albers JJ, Wijsman E, Zhang Z, Chapman NH, Kennedy H. Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans. J Lipid Res. 1996;37(12):2569-85.
22. Goldenberg NA, Hathaway WE, Jacobson L, Manco-Johnson MJ. A new global assay of coagulation and fibrinolysis. Thromb Res. 2005;116(4):345-56.
23. Goldenberg NA, Hathaway WE, Jacobson L, McFarland K, Manco-Johnson MJ. Influence of factor VIII on overall coagulability and fibrinolytic potential of haemophilic plasma as measured by global assay: monitoring in haemophilia A. Haemophilia. 2006;12(6): 605-14.
24. Goldenberg NA, Bombardier C, Hathaway WE, McFarland K, Jacobson L, Manco- Johnson MJ. Influence of factor IX on overall plasma coagulability and fibrinolytic potential as measured by global assay: monitoring in haemophilia B. Haemophilia. 2008;14(1): 68-77.
25. Bombardier C, Villalobos-Menuey E, Ruegg K, Hathaway WE, Manco-Johnson MJ, Goldenberg NA. Monitoring hypercoagulability and hypofibrinolysis following acute venous thromboembolism in children: application of the CloFAL assay in a prospective inception cohort study. Thromb Res. 2012; 130(3):343-9.
26. Smith AA, Jacobson LJ, Miller BI, Hathaway WE, Manco-Johnson MJ. A new euglobulin clot lysis assay for global fibrinolysis. Thromb Res. 2003; 112(5-6):329-37.
27. Kenet G, Lütkhoff LK, Albisetti M, Bernard T, Bonduel M, Brandao L, et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation. 2010;121(16):1838-47.